IC
ANRO icon

IEQ Capital’s Alto Neuroscience ANRO Stock Holding History

IEQ Capital’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
7,988
-15,739
-66% -$364K ﹤0.01% 1817
2026
Q1 		$533K Sell
23,727
-51,567
-68% -$956K ﹤0.01% 1277
2025
Q4 		$1.34M Buy
75,294
+12,315
+20% +$155K ﹤0.01% 926
2025
Q3 		$253K Sell
62,979
-2,210
-3% -$7.33K ﹤0.01% 1589
2025
Q2 		$143K Hold
65,189
– – ﹤0.01% 1672
2025
Q1 		$141K Hold
65,189
– – ﹤0.01% 1437
2024
Q4 		$276K Hold
65,189
– – ﹤0.01% 1059
2024
Q3 		$746K Buy
+65,189
New +$798K 0.01% 629

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

IEQ Capital's ANRO Position: Q2 2026 in Review

IEQ Capital reduced its Alto Neuroscience (ANRO) stake by 66% in Q2 2026, selling an estimated $364K and leaving 7,988 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

IEQ Capital first reported a position in ANRO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.34M in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • IEQ Capital held 7,988 shares of Alto Neuroscience worth $211K as of Q2 2026.
  • IEQ Capital sold 15,739 Alto Neuroscience shares in Q2 2026, an estimated $364K.
  • Alto Neuroscience made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1817 holding.
  • IEQ Capital first reported a position in Alto Neuroscience in Q3 2024 and has held it in 8 quarters since.
  • IEQ Capital's Alto Neuroscience position peaked at $1.34M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.